Literature DB >> 35462648

Thyroid Cancer: Global Burden and Trends.

Jessica B Shank1, Chandrakanth Are1, Chelsea D Wenos1.   

Abstract

The incidence of thyroid cancer continues to increase, representing the 5th most common cancer type in the USA today (Sherman, Lancet 361(9356):501-11, 2003). The current study sought to analyze the global burden of thyroid cancer utilizing the publicly accessible GLOBOCAN database. An estimated 586,202 cases of thyroid cancer were reported in 2020, making thyroid cancer the 10th most common cancer worldwide. The majority of thyroid cancer cases occurred in countries with a high or very high Human Development Index (HDI), accounting for 91% of new cases. With respect to the World Health Organization (WHO) regions, the Western Pacific had the highest incidence of thyroid cancer accounting for 47.6% of cases despite representing only 25.4% of the world's population. Thyroid cancer incidence and mortality are expected to increase by 29.9% and 67%, respectively, by the year 2040. The African region is projected to experience the highest increase in both incidence (84.3%) and mortality (100.3%) over this time period. The results of our study demonstrate that the incidence and mortality of thyroid cancer vary by the geographic location and socio-economic status. Although the incidence was noted to be the highest in very high HDI countries and the Western Pacific region, mortality was noted to be disproportionately higher in the low HDI countries and African region. This may be due to discrepancies in access to care and/or environmental exposures such as ionizing radiation and iodine deficiency. Further measures are required to improve the outcomes from thyroid cancer regardless of the geographic location or socio-economic status. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  Geography; Global health; Incidence; Mortality; Sociodemographics; Thyroid cancer

Year:  2021        PMID: 35462648      PMCID: PMC8986939          DOI: 10.1007/s13193-021-01429-y

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  13 in total

1.  An epidemiologic study of thyroid cancer in Hawaii.

Authors:  L N Kolonel; J H Hankin; L R Wilkens; F H Fukunaga; M W Hinds
Journal:  Cancer Causes Control       Date:  1990-11       Impact factor: 2.506

2.  A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases.

Authors:  S Franceschi; S Preston-Martin; L Dal Maso; E Negri; C La Vecchia; W J Mack; A McTiernan; L Kolonel; S D Mark; K Mabuchi; F Jin; G Wingren; R Galanti; A Hallquist; E Glattre; E Lund; F Levi; D Linos; E Ron
Journal:  Cancer Causes Control       Date:  1999-12       Impact factor: 2.506

3.  Risk of thyroid cancer after exposure to 131I in childhood.

Authors:  Elisabeth Cardis; Ausrele Kesminiene; Victor Ivanov; Irina Malakhova; Yoshisada Shibata; Valeryi Khrouch; Vladimir Drozdovitch; Evaldas Maceika; Irina Zvonova; Oleg Vlassov; André Bouville; Guennadi Goulko; Masaharu Hoshi; Alexander Abrosimov; Jadvyga Anoshko; Larisa Astakhova; Sergey Chekin; Evgenyi Demidchik; Rosaria Galanti; Masahiro Ito; Elena Korobova; Evgenyi Lushnikov; Marat Maksioutov; Vladimir Masyakin; Alexander Nerovnia; Vladimir Parshin; Evgenyi Parshkov; Nikolay Piliptsevich; Aldo Pinchera; Semyon Polyakov; Nina Shabeka; Eero Suonio; Vanessa Tenet; Anatoli Tsyb; Shunichi Yamashita; Dillwyn Williams
Journal:  J Natl Cancer Inst       Date:  2005-05-18       Impact factor: 13.506

Review 4.  Thyroid carcinoma.

Authors:  Steven I Sherman
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

5.  NORDCAN--a Nordic tool for cancer information, planning, quality control and research.

Authors:  Gerda Engholm; Jacques Ferlay; Niels Christensen; Freddie Bray; Marianne L Gjerstorff; Asa Klint; Jóanis E Køtlum; Elínborg Olafsdóttir; Eero Pukkala; Hans H Storm
Journal:  Acta Oncol       Date:  2010-06       Impact factor: 4.089

6.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

Review 9.  Differentiated Thyroid Cancer-Treatment: State of the Art.

Authors:  Benedikt Schmidbauer; Karin Menhart; Dirk Hellwig; Jirka Grosse
Journal:  Int J Mol Sci       Date:  2017-06-17       Impact factor: 5.923

10.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Authors:  J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray
Journal:  Int J Cancer       Date:  2018-12-06       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.